A novel genetic mutation in a Turkish family with GCK-MODY

被引:0
|
作者
S. Ahmet Ucakturk
Figen Gunindi
Serdar Ceylaner
Eda Mengen
Selin Elmaogulları
Bilgin Yuksel
机构
[1] Ankara Children’s Hematology and Oncology Training Hospital,Department of Pediatric Endocrinology
[2] Medical Park Hospital,Department of Pediatric Endocrinology
[3] Intergen Laboratory,Human Genetics
[4] Çukurova University,Department of Pediatric Endocrinology
关键词
GCK-MODY; Obese patient; Novel mutation;
D O I
暂无
中图分类号
学科分类号
摘要
Glucokinase-maturity-onset diabetes of the young (GCK-MODY) is an autosomal dominantly inherited disease caused by heterozygous inactivating mutations in the glucokinase gene. It usually presents with mild fasting hyperglycemia. Here, we present an obese patient and her family with GCK-MODY caused by a novel heterozygous p.E51*(c.151.G>T) mutation in the GCK gene.
引用
收藏
页码:323 / 326
页数:3
相关论文
共 50 条
  • [1] A novel genetic mutation in a Turkish family with GCK-MODY
    Ucakturk, S. Ahmet
    Gunindi, Figen
    Ceylaner, Serdar
    Mengen, Eda
    Elmaogullari, Selin
    Yuksel, Bilgin
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2017, 37 (03) : 323 - 326
  • [2] A novel genetic mutation in a Portuguese family with GCK-MODY
    Almeida, Claudia
    Silva, Sonia Regina
    Garcia, Elsa
    Leite, Ana Luisa
    Teles, Andreia
    Campos, Rosa Armenia
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (1-2): : 129 - 133
  • [3] Identification of a novel glucokinase mutation in an Indian woman with GCK-MODY
    Jha, Sujeet
    Siddiqui, Samreen
    Waghdhare, Swati
    Dubey, Shweta
    Krishna, Shuba
    Subramanian, Kalyanasundaram
    Dikshit, Jyoti Bajpai
    Ravikiran, L.
    Bhargava, Amit
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (04): : 302 - 302
  • [4] Distinct Effects of a Novel GCK-MODY Mutation on Lipid Profiles and Diabetic Complications
    Huang, Yadi
    Fan, Yuxin
    Li, Xin
    Ji, Shuhui
    Chen, Shanshan
    Cui, Jingqiu
    Feng, Wenli
    Shu, Hua
    Liu, Ming
    DIABETES, 2023, 72
  • [5] Clinical, Laboratory and Genetic Characteristics of Children with GCK-MODY (MODY2): Report of Four Novel Variants in GCK Gene
    Altan, Mustafa
    Anik, Ayse
    Bayar, Nilay Tugce Isik
    Bozkurt, Gokay
    Unuvar, Tolga
    Anik, Ahmet
    TRENDS IN PEDIATRICS, 2020, 1 (01): : 5 - 10
  • [6] Genetic and bioinformatics analysis of four novel GCK missense variants detected in Caucasian families with GCK-MODY phenotype
    Costantini, S.
    Malerba, G.
    Contreas, G.
    Corradi, M.
    Vargas, S. P. Marin
    Giorgetti, A.
    Maffeis, C.
    CLINICAL GENETICS, 2015, 87 (05) : 440 - 447
  • [7] GCK-MODY: Is Dorzagliatin safe and effective?
    Simon, Annika
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (05) : 317 - 318
  • [8] Management of hyperglycemia in GCK-MODY Pregnancies
    Wong, E.
    Ng, N.
    Bacon, S.
    Byrne, M. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S225 - S225
  • [9] GCK-MODY frequently misdiagnosed and inappropriately treated
    Boyd, S.
    McCaffrey, F. G.
    Bacon, S.
    Zamuner, Mijares M. B.
    Byrne, M. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 : S357 - S358
  • [10] Quality of life assessment in patients with genetic diagnosis of HNF1A-MODY and GCK-MODY
    Szopa, M.
    Matejko, B.
    Ucieklak, D.
    Uchman, A.
    Zapala, B.
    Platek, T.
    Hohendorff, J.
    Mrozinska, S.
    Malecki, M.
    DIABETOLOGIA, 2016, 59 : S165 - S165